These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33292545)

  • 41. Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.
    Fernberg JO; Wiklund T; Monge O; Hall KS; Saeter G; Alvegård TA; Strander H
    Acta Orthop Scand Suppl; 1999 Jun; 285():62-8. PubMed ID: 10429625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
    Willner A; Agaimy A; Fechner K; Ott O; Denz A; Weissmann T; Meidenbauer N; Höfler D; Gaipl U; Frey B; Schmidt M; Haller F; Horch R; Hartmann A; Grützmann R; Fietkau R; Semrau S
    Int J Hyperthermia; 2023; 40(1):2248424. PubMed ID: 37611915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).
    Jakob J; Simeonova A; Kasper B; Ronellenfitsch U; Rauch G; Wenz F; Hohenberger P
    Radiat Oncol; 2016 Jun; 11():77. PubMed ID: 27255678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall.
    Jebsen NL; Engellau J; Engström K; Bauer HC; Monge OR; Muren LP; Eide GE; Trovik CS; Bruland OS
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):949-55. PubMed ID: 23725998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience.
    Assi T; Cavalcanti A; Le Cesne A; Faron M; Honart JF; Hadiji A; Camuzard O; Ibrahim T; LePéchoux C; Mir O; Dumont S; Terrier P; Adam J; Honoré C
    Clin Transl Oncol; 2019 Sep; 21(9):1135-1141. PubMed ID: 30656606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soft tissue sarcoma in children: prognosis and management.
    Koscielniak E; Morgan M; Treuner J
    Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant treatment with preoperative radiotherapy for extremity soft tissue sarcomas: long-term results from a single institution in Turkey.
    Dincbas FO; Oksuz DC; Yetmen O; Hiz M; Dervisoglu S; Turna H; Kantarci F; Mandel NM; Koca S
    Asian Pac J Cancer Prev; 2014; 15(4):1775-81. PubMed ID: 24641408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic overview of radiation therapy effects in soft tissue sarcomas.
    Strander H; Turesson I; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):516-31. PubMed ID: 14596510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma.
    Casper ES; Gaynor JJ; Harrison LB; Panicek DM; Hajdu SI; Brennan MF
    Cancer; 1994 Mar; 73(6):1644-51. PubMed ID: 8156491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
    San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.
    Pennington JD; Eilber FC; Eilber FR; Singh AS; Reed JP; Chmielowski B; Eckardt JJ; Bukata SV; Bernthal NM; Federman N; Nelson SD; Dry SM; Wang PC; Luu M; Selch MT; Steinberg ML; Kalbasi A; Kamrava M
    Am J Clin Oncol; 2018 Dec; 41(12):1154-1161. PubMed ID: 29664796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
    Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol.
    Spencer RM; Aguiar Junior S; Ferreira FO; Stevanato Filho PR; Kupper BE; Silva ML; Mello CA; Bezerra TS; Lopes A
    JMIR Res Protoc; 2017 May; 6(5):e97. PubMed ID: 28546135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.
    Pisters PW; Patel SR; Varma DG; Cheng SC; Chen NP; Nguyen HT; Feig BW; Pollack A; Pollock RE; Benjamin RS
    J Clin Oncol; 1997 Dec; 15(12):3481-7. PubMed ID: 9396401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.
    Trovik C; Bauer HCF; Styring E; Sundby Hall K; Vult Von Steyern F; Eriksson S; Johansson I; Sampo M; Laitinen M; Kalén A; Jónsson H; Jebsen N; Eriksson M; Tukiainen E; Wall N; Zaikova O; Sigurðsson H; Lehtinen T; Bjerkehagen B; Skorpil M; Egil Eide G; Johansson E; Alvegard TA
    Acta Orthop; 2017 Jun; 88(3):341-347. PubMed ID: 28266233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
    Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
    Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.